Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Coupling single-pass TFF before loading onto a chromatography sorbent
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
View All Featured ArticlesHeadline News
Kyverna completes BLA submission for miv-cel in stiff person syndrome
CHMP recommends Gazyva/Gazyvaro for systemic lupus erythematosus
FDA approves Klygefa for adults with generalised myasthenia gravis
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Best Practices of Downstream Protein Purification and Product Concentration
Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Director at Biocon Biologics, Sofie Östemar, Product Manager for Connected & Continuous Downstream Processing and Henrik Ihre, Ph.D. Director Strategic Technologies at Cytiva and Nigel Jackson Principal Engineer, Bioprocessing R&D at Pall Corporation
12th October 2022
Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up
Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and Thomas Müller-Späth, Ph.D, CTO at YMC ChromaCon
10th March 2020
Points To Consider: Demonstrating Comparability Between Recombinant and Lysate Reagent For BET Testing
Presented by Karen Zink McCullough, Owner, Principal Consultant at MMI Associates, Nicola Reid, Associate Director Product Management, Endotoxin Products at Charles River Laboratories and Veronika Wills, Manager, Technical Services At Associates of Cape Cod, Inc
09th September 2021
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Strategy Emerging Markets for Risk Mitigation
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















